|
Variable
|
N
|
FOXA1-negative (%)
|
FOXA1-positive (%)
|
P value
|
n
|
GATA3-negative (%)
|
GATA3-positive (%)
|
P value
|
|---|
|
EGFR
|
223
| | | |
203
| | | |
|
Positive
|
13
|
10 (7.6)
|
3 (3.3)
|
0.171
|
11
|
11 (10.4)
|
0 (0)
|
0.001
|
|
Negative
|
210
|
121 (92.4)
|
89 (96.7)
| |
192
|
95 (89.6)
|
97 (100)
| |
|
P-cadherin
|
220
| | | |
202
| | | |
|
Positive
|
75
|
53 (40.8)
|
22 (24.4)
|
0.012
|
71
|
52 (49.1)
|
19 (19.8)
|
<0.0001
|
|
Negative
|
145
|
77 (59.2)
|
68 (75.6)
| |
131
|
54 (50.9)
|
77 (80.2)
| |
|
Cytokeratin 5
|
224
| | | |
204
| | | |
|
Positive
|
50
|
36 (27.5)
|
14 (15)
|
0.027
|
48
|
39 (36.4)
|
9 (9.3)
|
<0.0001
|
|
Negative
|
174
|
95 (72.5)
|
79 (85)
| |
156
|
68 (63.6)
|
88 (90.7)
| |
|
Cytokeratin 14
|
219
| | | |
201
| | | |
|
Positive
|
14
|
13 (10.1)
|
1 (1.5)
|
0.007
|
14
|
14 (13.3)
|
0 (0)
|
0.0002
|
|
Negative
|
205
|
116 (89.9)
|
89 (98.9)
| |
187
|
91 (86.7)
|
96 (100)
| |
|
Vimentin
|
203
| | | |
194
| | | |
|
Positive
|
34
|
28 (23.1)
|
6 (7.3)
|
0.003
|
32
|
26 (25)
|
6 (6.7)
|
0.0006
|
|
Negative
|
169
|
93 (76.9)
|
76 (92.7)
| |
162
|
78 (75)
|
84 (93.3)
| |
|
FOXA1
|
-
|
-
|
-
|
-
|
201
| | | |
|
Positive
|
-
|
-
|
-
| |
82
|
16 (15.4)
|
66 (68)
|
<0.0001
|
|
Negative
|
-
|
-
|
-
| |
119
|
88 (84.6)
|
31 (32)
| |
|
GATA-3
|
201
| | | |
-
|
-
|
-
|
-
|
|
Positive
|
97
|
31 (26.1)
|
66 (80.5)
|
<0.0001
|
-
|
-
|
-
| |
|
Negative
|
104
|
88 (73.9)
|
16 (19.5)
| |
-
|
-
|
-
| |
|
Subtype
|
202
| | | |
187
| | | |
|
Luminal A
|
125
|
56 (47)
|
69 (83.1)
|
<0.0001
|
114
|
36 (36.7)
|
78 (87.7)
|
<0.0001
|
|
Luminal B
|
8
|
4 (3.4)
|
4 (4.8)
| |
8
|
5 (5.1)
|
3 (3.4)
| |
|
HER-2
|
27
|
23 (19.3)
|
4 (4.8)
| |
26
|
24 (24.5)
|
2 (2.2)
| |
|
Basal
|
42
|
36 (30.3)
|
6 (7.3)
| |
39
|
33 (33.7)
|
6 (6.7)
| |
- FOXA-1, forkhead box A1; GATA-3, GATA binding protein 3; EGFR, epidermal growth factor receptor; HER-2, human epidermal growth factor receptor 2.
